BION-1301 Treatment Results in Clinically Meaningful Proteinuria Reductions in Patients with IgAN

Mean reduction in UPCR of 53.8 % at 24 weeks in Cohort 2 with de novo SC administration of BION-1301 are consistent with those observed in Cohort 1

Mean reduction in UPCR of 53.8 % at 24 weeks in Cohort 2 with de novo SC administration of BION-1301 are consistent with those observed in Cohort 1

Format

PNG

Source

Chinook Therapeutics, Inc.

Downloads